MedTrace Logo

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI

NCT01781715 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-02-01

No results posted yet for this study

Summary

The purpose of this study is to determine outcomes (death, myocardial infarction, target vessel revascularization (TVR), non-target vessel revascularization (non-TVR), stent-thrombosis) of 120 consecutive patients with ST elevation myocardial infarction and multivessel coronary artery disease undergoing multivessel stenting or staged percutaneous coronary intervention with Zotarolimus-eluting stents

Conditions

  • ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Interventions

DEVICE

Zotarolimus-eluting coronary stent

Multivessel stenting or Staged PCI with Zotarolimus-eluting coronary stent in STEMI patients

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Russian Academy of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01781715 on ClinicalTrials.gov